Skip to main content
Fig. 6 | Diabetology & Metabolic Syndrome

Fig. 6

From: Potential therapeutic effects of endothelial cells trans-differentiated from Wharton’s Jelly-derived mesenchymal stem cells on altered vascular functions in aged diabetic rat model

Fig. 6

Antioxidant effects of MSCs-derived ECs. a Serum level of malondialdhyde (MDS) in aged control (white column), aged diabetic (black column) and aged diabetic + ECs treated (grey column) groups. b Serum level of reactive oxygen species (ROS) in aged control (white column), aged diabetic (black column) and aged diabetic + ECs treated (grey column) groups. c Serum level of advanced glycation end products (AGEs) in aged control (white column), aged diabetic (black column) and aged diabetic + ECs treated (grey column) groups. (*Significant (p < 0.05), ns = non significant. Number of rats = 10/group)

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us